Pittsburgh Post-Gazette

Fla. can import prescripti­on drugs from Canada, FDA says

- By Matthew Perrone

WASHINGTON — The Food and Drug Administra­tion on Friday cleared the way for Florida’s first-in-thenation plan to import prescripti­on drugs from Canada, a long-sought approach to accessing cheaper medication­s that follows decades of frustratio­n with U.S. drug prices.

Republican Gov. Ron DeSantis signed the plan into law in 2019, but it required federal review and approval by the FDA, which controls prescripti­on drug imports.

Democratic President Joe Biden has backed such programs as a way to lower prices, signing an executive order in 2021 that directed the FDA to work with states on imports.

The policy change represente­d a shift after years of successful lobbying by the pharmaceut­ical industry, which said imports would expose U.S. patients to risks of counterfei­t or adulterate­d drugs. The FDA also previously warned of the difficulti­es of assuring the safety of drugs originatin­g from outside the U.S.

But the politics surroundin­g the issue have shifted in recent years, with both parties — including former President Donald Trump — doubling down on the import approach.

The FDA said Florida’s program will be authorized for two years, though imports won’t begin immediatel­y. Under federal requiremen­ts, state officials must first test the drugs to make sure they’re authentic and relabel them so that they comply with U.S. standards.

Florida’s health department must also provide a quarterly report to the FDA on the types of drugs imported, cost savings and any potential safety and quality issues.

“These proposals must demonstrat­e the programs would result in significan­t cost savings to consumers without adding risk of exposure to unsafe or ineffectiv­e drugs,” FDA Commission­er Dr. Robert Califf said in a statement.

The FDA action was first reported by The New York Times.

Mr. DeSantis, who is battling Mr. Trump for the Republican presidenti­al nomination, previously sued the Biden administra­tion for allegedly delaying approval of the import program. Several other states also are awaiting federal approval.

The FDA is likely to face legal challenges over the decision, which the pharmaceut­ical industry’s trade group called “a serious danger to public health.”

“We are deeply concerned with the FDA’s reckless decision to approve Florida’s state importatio­n plan,” the Pharmaceut­ical Research and Manufactur­ers of America said in a statement Friday.

Many people already buy at least some of their medicines from pharmacies in Canada or Mexico, although technicall­y it’s illegal to import them. Work on allowing state imports began under Mr. Trump, a relentless critic of industry pricing.

Under the current regulation­s, states can import certain medicines through pharmacies and wholesaler­s. DeSantis has previously estimated taxpayers could save up to $150 million annually under the program. The state’s proposal includes a number of drug classes, including medication­s for asthma; chronic obstructiv­e pulmonary disease, or COPD; diabetes; HIV and AIDS; and mental illness.

The medication­s would be only for certain people, including foster children, inmates, certain elderly patients and — eventually — Medicaid recipients.

Newspapers in English

Newspapers from United States